Carlo Brugnara

Carlo Brugnara

Harvard University

H-index: 88

North America-United States

About Carlo Brugnara

Carlo Brugnara, With an exceptional h-index of 88 and a recent h-index of 42 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Medicine-Hematology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Nrf2 Plays a Key Role in Erythropoiesis during Aging

Acute promyelocytic leukemia with torque teno mini virus (TTMV):: RARA fusion: an approach to screening and diagnosis

Mitapivat, a pyruvate kinase activator, improves transfusion burden and reduces iron overload in β-thalassemic mice

P1458: MITAPIVAT AMELIORATES IN VITRO HUMAN Β THALASSEMIC ERYTHROID MATURATION INDEX AND MODULATES THE EXPRESSION OF THE CYTOPROTECTOR PEROXIREDOXIN-2.

Variation and impact of polygenic hematologic traits in monogenic sickle cell disease

Mitapivat Treatment Increases β-Thalassemic Erythroblasts Energy Production and Responsiveness to Oxidative Stress

In Humanized Sickle Cell Mice, Imatinib Protects Against Sickle Cell–Related Injury

17R-Resolvin D1 Improves Inflammatory Cardiomyopathy in a Mouse Model of Sickle Cell Disease

Carlo Brugnara Information

University

Position

Professor of Pathology, Harvard Medical School

Citations(all)

27529

Citations(since 2020)

6212

Cited By

24248

hIndex(all)

88

hIndex(since 2020)

42

i10Index(all)

251

i10Index(since 2020)

136

Email

University Profile Page

Harvard University

Google Scholar

View Google Scholar Profile

Carlo Brugnara Skills & Research Interests

Medicine-Hematology

Top articles of Carlo Brugnara

Title

Journal

Author(s)

Publication Date

Nrf2 Plays a Key Role in Erythropoiesis during Aging

Antioxidants

Serge Cedrick Toya Mbiandjeu

Angela Siciliano

Alessandro Mattè

Enrica Federti

Massimiliano Perduca

...

2024/4/12

Acute promyelocytic leukemia with torque teno mini virus (TTMV):: RARA fusion: an approach to screening and diagnosis

medRxiv

Harrison K Tsai

Mark F Sabbagh

Meagan Montesion

Erik A Williams

Arnaldo Arbini

...

2024

Mitapivat, a pyruvate kinase activator, improves transfusion burden and reduces iron overload in β-thalassemic mice

Haematologica

Alessandro Mattè

Penelope A Kosinski

Enrica Federti

Lenny Dang

Antonio Recchiuti

...

2023/9/9

P1458: MITAPIVAT AMELIORATES IN VITRO HUMAN Β THALASSEMIC ERYTHROID MATURATION INDEX AND MODULATES THE EXPRESSION OF THE CYTOPROTECTOR PEROXIREDOXIN-2.

HemaSphere

Richard Pozzetto Huot

Andrea Mattarei

Alberto Ongaro

Alice Passarini

Angela Siciliano

...

2023/8/1

Variation and impact of polygenic hematologic traits in monogenic sickle cell disease

Haematologica

Thomas Pincez

Ken Sin Lo

Anne-Laure Pham Hung d’Alexandry

Melanie E Garrett

Carlo Brugnara

...

2023/3/3

Mitapivat Treatment Increases β-Thalassemic Erythroblasts Energy Production and Responsiveness to Oxidative Stress

Blood

Alessandro Mattè

Angelo D'Alessandro

Mariarita Bertoldi

Richard Huot Pozzetto

Giovanni Bisello

...

2023/11/28

In Humanized Sickle Cell Mice, Imatinib Protects Against Sickle Cell–Related Injury

Hemasphere

Enrica Federti

Alessandro Matte

Antonio Recchiuti

Francesca Garello

Alessandra Ghigo

...

2023/3/1

17R-Resolvin D1 Improves Inflammatory Cardiomyopathy in a Mouse Model of Sickle Cell Disease

Blood

Enrica Federti

Domenico Mattoscio

Antonio Recchiuti

Alessandro Mattè

Maria Monti

...

2023/11/28

Immune therapies in the treatment of multiple myeloma

Carlo Brugnara

2023/3/1

Mitapivat reprograms the RBC metabolome and improves anemia in a mouse model of hereditary spherocytosis

JCI insight

Alessandro Matte

Anand B Wilson

Federica Gevi

Enrica Federti

Antonio Recchiuti

...

2023/10/10

Resolvins modulate netosis and autoimmunity in sickle cell disease

Blood

Alessandro Mattè

Antonio Recchiuti

Enrica Federti

Filippo Mazzi

Jacopo Ceolan

...

2022/11/15

P1483: EPELEUTON, A NOVEL SYNTHETIC SECOND GENERATION W-3 FATTY ACID, PROTECTS HUMANIZED SICKLE CELL MICE AGAINST HYPOXIA/REOXYGENATION ORGAN DAMAGE

HemaSphere

E Federti

A Matte

M Hamza

A Lafferty

D Coughlan

...

2022/6/1

Evidence of noninferiority of mitapivat versus splenectomy in murine hereditary spherocytosis

EHA. Wein: Hemasphere

ARA Matte

E Federti

PA Kosinski

2022

Purinergic signaling is essential for full Psickle activation by hypoxia and by normoxic acid pH in mature human sickle red cells and in vitro-differentiated cultured human …

Pflügers Archiv-European Journal of Physiology

David H Vandorpe

Alicia Rivera

Markus Ganter

Selasi Dankwa

Jay G Wohlgemuth

...

2022/5

Proteomic and Lipidomic Investigation of an Ex-Vivo Human Model of Sickle Cell Disease Erythropoiesis and Patient Erythrocytes Reveals the Abnormal Localization and Dysfunction …

Blood

Julien Delobel

Romain Hamelin

Viviane Praz

Hector Gallart-Ayala

Florence Armand

...

2022/11/15

Commentaries on Viewpoint: Consider iron status when making sex comparisons in human physiology

Journal of applied physiology (Bethesda, Md.: 1985)

Claire E Badenhorst

Grégoire P Millet

Tadej Debevec

Franck Brocherie

Alexandra M Coates

...

2022/3/1

Altered Cellular Sedimentation during Apheresis Impacts Outcomes of Peripheral Blood Stem Cell Collection Efficiency in Patients with Sickle Cell Disease

Blood

David G Justus

Erica B Esrick

Matthew M Heeney

Ellen Proeung

Carly Howard

...

2022/11/15

The Erythrocyte, a Novel Disease-Mediator for COVID-19 Vasculopathy?

Carlo Brugnara

2022/3/1

HbSC disease: A time for progress

Caterina Minniti

Carlo Brugnara

Martin H Steinberg

2022/11

Erythroid‐specific inactivation of Slc12a6/Kcc3 by EpoR promoter‐driven Cre expression reduces K‐Cl cotransport activity in mouse erythrocytes

Physiological Reports

Boris E Shmukler

Alicia Rivera

Katherine Nishimura

Ann Hsu

Jay G Wohlgemuth

...

2022/3

See List of Professors in Carlo Brugnara University(Harvard University)